Holzheimer René G
University of Halle-Wittenberg, Blombergstrasse 5, D-82054 Sauerlach, Germany.
Eur J Med Res. 2004 Jun 30;9(6):323-7.
There are about 200,000 hernia repairs per year in Germany and about 770,000 in the U.S. In the United States most hernia repairs (80-90%) are performed as day surgery procedure; 90% of operations are open herniorrhaphies with mesh. Quality control includes the registration of complications, recurrence, and quality of life. In a prospective study 50 consecutive patients with inguinal hernia eligible for open mesh repair (modified Lichtenstein hernia repair), mostly Nyhus III and IV classification, were operated using light-weight Ultrapro-mesh (monocryl-prolene-composite, Ethicon Products), and interviewed 10 days after the operation according to a modified SF-36 questionnaire. Patients were examined three months later. There were 29 direct hernias, 21 combined (direct and indirect) hernias, 8 indirect hernias; 8 patients had hernias on both sides. 8 patients (16%) presented with recurrent hernias, mostly suture or laparoscopic repairs before. There were no intra-operative complications. 2 patients suffered from a moderate haematoma, which did not necessitate a surgical repair, after accidental intake of aspirin preoperatively in one case and after preoperative low-molecular-weight heparin prophylaxis. There were no other complications. All 50 patients (100%) had returned the questionnaire. 38 patients (78%) reported no or mild pain; only one patient (2%) suffered from severe pain, none had very severe pain. 32 patients (64%) applied no pain medication or only for 48 hours; only one patient (2%) used pain medication for more than 14 days. 34 patients (68%) admitted that their health status improved after the operation; 11 patients (22%) with good or very good health status indicated no change in health. Follow-up examination of the patients three months after the operation did not detect any recurrence. 49 patients (98%) were free of pain or restriction; one patient (2%) continued to have chronic pain which developed after two laparoscopic herniotomies performed at a different clinic before. There was no sign of mesh-related complication. The Ultrapro-mesh has been well accepted by the patients. In conclusion, open mesh repair according to Lichtenstein is safely done in specialised ambulatory day surgery clinics. Most patients benefit from this form of treatment according to a quality of life audit. The new light-weight mesh Ultrapro contributes to the improvement of hernia repair. There is evidence that ambulatory open mesh repair should be the method of choice for primary inguinal hernia. If in Germany an equal proportion of hernia repair as in the United States would be done as ambulatory procedure (80-90%), there would be an annual cost saving of several hundred million Euro.
德国每年约有20万例疝气修补手术,美国约有77万例。在美国,大多数疝气修补手术(80%-90%)作为日间手术进行;90%的手术是使用补片的开放式疝修补术。质量控制包括并发症、复发情况和生活质量的登记。在一项前瞻性研究中,连续50例符合开放式补片修补术(改良利chtenstein疝修补术)的腹股沟疝患者,大多为Nyhus III级和IV级分类,使用轻质Ultrapro补片(单丝丙纶复合材料,Ethicon产品)进行手术,并在术后10天根据改良的SF-36问卷进行访谈。三个月后对患者进行检查。有29例直疝、21例复合(直疝和斜疝)疝、8例斜疝;8例患者双侧有疝。8例患者(16%)为复发性疝,大多之前接受过缝合或腹腔镜修补术。术中无并发症。2例患者出现中度血肿,1例术前意外服用阿司匹林,另1例术前接受低分子肝素预防后出现中度血肿,均无需手术修复。无其他并发症。所有50例患者(100%)都返回了问卷。38例患者(78%)报告无疼痛或轻度疼痛;只有1例患者(2%)遭受重度疼痛,无患者遭受极重度疼痛。32例患者(64%)未使用止痛药物或仅使用了48小时;只有1例患者(2%)使用止痛药物超过14天。34例患者(68%)承认术后健康状况有所改善;11例健康状况良好或非常良好的患者表示健康状况无变化。术后三个月对患者进行随访检查未发现任何复发。49例患者(98%)无疼痛或受限情况;1例患者(2%)仍有慢性疼痛,该疼痛在之前另一家诊所进行的两次腹腔镜疝修补术后出现。无补片相关并发症的迹象。Ultrapro补片已被患者很好地接受。总之,在专门的门诊日间手术诊所中,按照利chtenstein方法进行开放式补片修补术是安全的。根据生活质量评估,大多数患者受益于这种治疗方式。新型轻质补片Ultrapro有助于改善疝气修补术。有证据表明,门诊开放式补片修补术应是原发性腹股沟疝的首选方法。如果在德国,与美国相同比例(80%-90%)的疝气修补手术作为门诊手术进行,每年将节省数亿欧元的成本。